Back to 
HERSHEY TRUST CO
HERSHEY TRUST CO
CRSPShowing 0 of 14 quarters
Position history for HERSHEY TRUST CO's holdings in CRISPR THERAPEUTICS AG
No. Hershey Trust exited its CRSP (Crispr Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 33,758 shares worth $1.5M. Hershey Trust first reported CRSP in Q3 2020 and held it in 12 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors